Insider buying last 90 days
No open-market insider purchases were filed for PEN in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every PEN insider filing, plotted on the chart in Gekko.Open PEN in Gekko
NYSE: PEN
Penumbra (PEN) Stock Analysis & Forecast
Sep 28 close
$319.18+0.29 (+0.1%)
Gekko Brief
AI summaryThis week's coverage of Penumbra centers on valuation and technical analysis rather than company-specific news. Several pieces weigh the stock's growth profile against its price, with one analysis noting shares trading near $317.60 versus a modeled fair value estimate, and another citing a market cap of $12.51 billion alongside an average analyst target suggesting further upside. A separate piece using AI-based technical models describes a neutral near and mid-term outlook with a longer-term positive bias.
Penumbra closed at $319.18, up 0.1%, sitting below both its 50-day average of $321.56 and its 200-day average of $326.65, with the shorter average also below the longer one, reflecting a headwind trend. The GekkoIndex reads 59.9, placing the stock in the Neutral zone, down from a five-day change of -4.8. Gekko Fair Value stands at $337.66, putting the current price about 5.5% below that level.
Looking ahead, Penumbra's next earnings report is scheduled for 4 November 2026 after the close, 36 days out and beyond a typical 20-trading-day holding window; the prior report on 30 July showed EPS of $0.88 against an estimate of $1.15, with a 0.3% reaction, and the company has beaten estimates in 6 of the last 8 quarters. No insider, Congress, or unusual options activity appears in the current windows. Seasonality over the next 20 trading days has averaged -2.1% across 5 years, rising in 2 of them, a pattern worth noting alongside analyst coverage showing 1 buy and 5 hold ratings among 6 firms.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Penumbra price vs fair value
Close $319.18200-day averageGekko Fair Value $337.66
Penumbra quick facts
- Market cap
- $12.57B
- P/E ratio
- 78.8
- Forward P/E
- 55.6
- EPS, TTM
- $4.06
- Revenue, TTM
- $1.50B
- Profit margin
- 10.7%
- Dividend yield
- —
- Beta
- 0.70
- Volume
- 189,475 avg 370,243
- 1-year return
- +28.1%
- Typical daily move
- ±0.5%
- Typical 20-day move
- ±7%
- 50-day average
- $321.56
- 200-day average
- $326.65
- Next earnings
- Nov 4 after close
- Shares outstanding
- 39.39M
Penumbra swing-trade checklist
Penumbra scores 2 supportive, 1 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed2 headwinds
- Trendheadwind
Below 50 and 200-day
Close $319.18 is below the 50-day ($321.56) and 200-day ($326.65) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexmixed
59.9, Neutral
Reading 59.9 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
5.5% below
Price is 5.5% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 36 days
Next report Nov 4, 2026, 36 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−2.1% on average
From this point in the calendar, the next 20 trading days averaged −2.1% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Penumbra stock chart and price history
Penumbra closed at $319.18 on Sep 28, 2026, +28.1% over the past year, inside a 52-week range of $221.26 to $362.41.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −0.6%
- 3 months
- +1.2%
- 6 months
- −4.8%
- 1 year
- +28.1%
The full PEN chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open PEN in Gekko
Follow Penumbra through every session
Put PEN on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track PEN in GekkoFree for 7 days. No credit card required.
About Penumbra
Penumbra designs, manufactures and sells medical devices used to treat vascular and neurological conditions, with products sold across the United States and in other countries. It is best known for its thrombectomy systems, tools that use vacuum or mechanical aspiration to clear blood clots from vessels in the body and brain, including devices such as the Indigo System, Lightning Flash and Lightning Bolt 7.
Beyond thrombectomy, Penumbra makes a wide set of related tools, among them guide catheters and delivery catheters for accessing blood vessels, an integrated reperfusion system for mechanical thrombectomy, coiling systems used to treat aneurysms and other vascular lesions, embolization devices for peripheral use, and a neurosurgical device for removing fluid and tissue from the brain. These products reach hospitals and medical practitioners through the company's own direct sales teams as well as through outside distributors.
Penumbra was incorporated in 2004 and operates out of Alameda, California. Its shares are listed on the NYSE under the ticker PEN.
- Listed
- NYSE
- Sector
- Health technology
- Industry
- Medical specialties
- Website
- penumbrainc.com
Penumbra GekkoIndex: the smart money zone
Penumbra’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 59.9, in the Neutral zone, down 4.8 points over five sessions.
59.9Neutral
Down 4.8 points over five sessions, from the Accumulation zone.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 32 | +2.2% | +7.4% | ||
| Accumulation | 282 | 0.0% | −0.8% | ||
| Neutral (current zone) | 323 | +0.5% | +2.2% | ||
| Distribution | 34 | −1.3% | −1.8% | ||
| Selling | 1 | Too few readings yet | |||
Average PEN share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the PEN price, zone by zone.Track PEN in Gekko
Is Penumbra stock overvalued? Gekko Fair Value
Penumbra trades 5.5% below Gekko Fair Value of $337.66, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Penumbra shares are worth, recalculated every trading day.
$337.66
Gekko Fair Value, Sep 26, 2026
5.5% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open PEN in Gekko
Penumbra insider and Congress trading
No open-market insider purchases were filed for Penumbra, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in PEN were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for PEN, plotted on the chart in Gekko.Open PEN in Gekko
Buybacks
Penumbra has been buying back its own shares.
- Bought back, quarter ended Mar 31, 2026
- $1.29M
- As a share of market cap
- 0.01%
From company filings.
Hedge funds and billionaires quarter ended Jun 30
1of the funds Gekko tracks holds PEN.
1added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Penumbra earnings: next date and track record
Penumbra reports on Nov 4, 2026, after the close (36 days away), and beat the EPS estimate in 6 of its last 8 reports.
Next earnings report
Nov 4, 2026
Expected after the close, 36 days away
- EPS estimate
- $1.20
- Revenue estimate
- $401.4M
6 of 8reports beat the EPS estimate
±6.8%average move across the report
8 of 8reports followed by a gain
Share-price move across each report
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 30, 2026 | $0.88 est $1.15 | $390.0M est $389.6M | +0.3% |
| May 6, 2026 | $1.01 est $1.06 | $374.8M est $370.5M | +0.2% |
| Feb 25, 2026 | $1.18 est $1.10 | $385.4M est $361.9M | +0.7% |
| Nov 5, 2025 | $0.97 est $0.93 | $354.7M est $341.0M | +12.6% |
| Jul 29, 2025 | $0.86 est $0.81 | $339.5M est $341.3M | +10.4% |
| Apr 23, 2025 | $0.83 est $0.67 | $324.1M est $327.3M | +7.6% |
| Feb 18, 2025 | $0.97 est $0.89 | $315.5M est $311.6M | +13.1% |
| Oct 30, 2024 | $0.85 est $0.69 | $301.0M est $311.6M | +9.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Penumbra stock forecast and analyst price targets
Analysts’ average 12-month price target for Penumbra is $361.83, +13.4% from the last close, from 6 firms rating the stock in the last 90 days.
$361.83consensus 12-month target, +13.4% from the last close
Now $319.18Avg $361.83
Low $320High $374
Each firm’s latest rating in the last 90 days: 6 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Aug 4 | Canaccord Genuity | $374 | +17.2% |
| Aug 3 | Wells Fargo | $374 | +17.2% |
| Jul 31 | RBC Capital | $374 | +17.2% |
| Jul 31 | RBC Capital | $374 | +17.2% |
| Jul 13 | RBC Capital | $374 | +17.2% |
+2.2%average 20-day move after past Neutral readings
−2.1%average move over the next 20 trading days in the last 5 years
±0.5%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Penumbra seasonality: the next 20 trading days
Over the next 20 trading days from Sep 26, Penumbra averaged −2.1% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.1% | 3 of 5 |
| Next 10 trading days | −0.9% | 2 of 5 |
| Next 15 trading days | −1.9% | 2 of 5 |
| Next 20 trading days | −2.1% | 2 of 5 |
| Next 30 trading days | +1.8% | 3 of 5 |
For scale, PEN’s typical 20-trading-day move in either direction is about 7%.
Penumbra market cap and key statistics
Penumbra’s market cap is $12.57B, with a P/E ratio of 78.8 and revenue of $1.50B over the last twelve months.
Valuation
- Market cap
- $12.57B
- P/E ratio
- 78.8
- Forward P/E
- 55.6
- EPS, TTM
- $4.06
- Gekko Fair Value
- $337.66
Trading
- Volume
- 189,475
- Avg volume, 20 days
- 370,243
- 52-week high
- $362.41
- 52-week low
- $221.26
- Shares outstanding
- 39.39M
Financials
- Revenue, TTM
- $1.50B
- Profit margin
- 10.7%
- Return on equity
- 11.4%
- Quarterly earnings growth, YoY
- −23.5%
Risk and income
- Beta
- 0.70
- Typical daily move
- ±0.5%
- Typical 20-day move
- ±7%
Penumbra stock news this week
Coverage of Penumbra this week reads positive: 2 positive, 1 neutral and 0 negative headlines.
- The Technical Signals Behind (PEN) That Institutions FollowStock Traders Daily, Sep 26
- Penumbra, Inc. (PEN) Stock Analysis: Evaluating A 13.93% Upside PotentialDirectorsTalk Interviews, Sep 22
- Penumbra Inc. stock trades near 317 dollars as investors weigh growth and valuationAD HOC NEWS, Sep 21
Penumbra peers
Penumbra’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Distribution | 23.7% above |
| ABTAbbott Laboratories | Accumulation | 15.0% below |
| DHRDanaher | Distribution | 10.2% above |
| ISRGIntuitive Surgical | Neutral | 17.0% above |
| MDTMedtronic | Accumulation | 24.1% below |
| SYKStryker | Accumulation | 14.1% below |
A peer links to its own page where one exists.
Penumbra stock FAQ
What is Penumbra’s market cap?
Penumbra’s market cap is $12.57B at the Sep 28, 2026 close of $319.18, with 39.39M shares outstanding. The shares trade on a P/E ratio of 78.8.
What is the Penumbra stock forecast?
The consensus analyst 12-month price target for Penumbra is $361.83, +13.4% from the last close. Of the 6 firms that rated the stock in the last 90 days, 1 rate it a buy, 5 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Penumbra stock overvalued or undervalued?
On Gekko’s estimate Penumbra is undervalued: the Sep 28, 2026 close of $319.18 is 5.5% below Gekko Fair Value of $337.66. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Penumbra report earnings next?
Penumbra is expected to report on Nov 4, 2026, after the market closes (36 days away). Analysts expect earnings of $1.20 per share on revenue of $401.4M. Penumbra beat the earnings estimate in 6 of its last 8 reports, moving 6.8% on average across the report.
What is Penumbra’s 52-week high and low?
Penumbra’s 52-week high is $362.41 and its 52-week low is $221.26; it closed at $319.18 on Sep 28, 2026, +28.1% over the past year.
Is Penumbra stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (fair value and earnings risk), 1 as mixed (gekkoindex) and 2 as headwinds (trend and seasonality). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Penumbra the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.